| ELI LILLY |
| USA |
| Gesundheit |
| US5324571083 / 858560 |
| LLY (Frankfurt) / LLY (NYSE) |
| FRA:LLY, ETR:LLY, LLY:GR, NYSE:LLY |
| S&P500 |
| https://www.lilly.com/ |
|
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. Headquartered in Indianapolis, Indiana, the company focuses on therapies addressing diabetes, oncology, immunology, n..
>Volltext.. |
| 926071.48 Mio. EUR |
| 959027.82 Mio. EUR |
| 63590.68 Mio. EUR |
| 31873.98 Mio. EUR |
| 22245.89 Mio. EUR |
| 24.49 EUR |
| 38172.27 Mio. EUR |
| 4520.47 Mio. EUR |
| 18025.9 Mio. EUR |
| 0.14 |
| 38.06% |
| 113.09% |
| 5.52 EUR |
| 0.58% |
| 0.62% |
| 15.05.26 - 1.4872811€ 13.02.26 - 1.457352€ >weitere anzeigen... |
| ELI LILLY, LILLY DEUTSCHLAND |
| 26.06.26 |
|
||||
|
||||
|
||||
|